Johnson & Johnson (JNJ), Merck (MRK) and Eli Lilly (LLY) are collaborating in a global...
Thursday, November 15, 2012, 5:56 PM ETJohnson & Johnson (JNJ), Merck (MRK) and Eli Lilly (LLY) are collaborating in a global project to create a database aimed at getting patient tests of experimental drugs up and running more quickly and efficiently, which would eventually mean new medicines will get approved and reach patients sooner. The database will give drug companies working on experimental drugs a one-time approval process and drug makers a big pool of ready, qualified scientists with known expertise.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles